- Business Wire•10 days agoSIGA Announces Bankruptcy Court Approval of Transaction Under Which SIGA Will Pay PharmAthene Claim in Full
SIGA Technologies, Inc. ,SIGA Technologies, Inc., a company specializing in the commercialization of solutions for serious unmet medical needs and biothreats, announced today that the United States Bankruptcy Court for the Southern District of New York today entered an order approving SIGA’s proposed transaction under Option 1 of the Debtor’s Third Amended Chapter 11 Plan, dated April 7, 2016, under ...
- The Wall Street Journal•10 days ago
Smallpox drugmaker Siga is raising the money it needs to avoid a takeover by former business ally PharmAthene, ending a long legal saga that included a pass through bankruptcy.
- Business Wire•last monthSIGA Announces Completion of Enrollment and Dosing in the Final Cohort of Phase III Study of TPOXX™ (tecovirimat)
SIGA Technologies, Inc. , a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced completion of enrollment and dosing in the second and final cohort of healthy subjects for the Phase III clinical study for its lead drug candidate, TPOXX™ , for the treatment of orthopoxvirus infections.
SIGA Technologies, Inc. (SIGA)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||2.85 - 3.05|
|52wk Range||0.60 - 3.12|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-3.53|
|Avg Vol (3m)||78,095|
|Dividend & Yield||N/A (N/A)|